Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Regenxbio Inc
SWB:RB0
Regenxbio Inc
SWB:RB0
Price:
9.73
EUR
7.94%
Market Closed
Market Cap:
€813.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Regenxbio Inc
SWB:RB0
|
US |
|
Sultan Resources Ltd
OTC:SLZRF
|
AU |
|
China Communications Services Corp Ltd
F:CMW
|
HK |
|
S
|
Sigma Healthcare Ltd
OTC:SIGGF
|
AU |
|
Ellomay Capital Ltd
F:NUR
|
IL |
|
F
|
First Class Metals PLC
F:WN9
|
UK |
Wall St Price Targets
RB0 Price Forecast
Based on 13 analysts
Based on 13 analysts
+82% Upside
from
€9.73
today
Regenxbio Inc (RB0)’s 12-month stock price forecast through August 2027 has a consensus target of €17.75, implying 82% upside. The forecast is based on price targets from 13 Wall Street analysts.
RB0 Analyst Rating
No ratings yet
No ratings yet
Regenxbio Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RB0's stock price target?
Price Target
17.75
EUR
17.75
EUR
According to Wall Street analysts, the average 1-year price target for RB0 is 17.75 EUR with a low forecast of 8.79 EUR and a high forecast of 45.68 EUR.
What is the Revenue forecast for Regenxbio Inc?
Projected CAGR
29%
29%
Over the last 11 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 29%.
What is the Gross Profit forecast for Regenxbio Inc?
Projected CAGR
28%
28%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 8 years is 28%.